Literature DB >> 18336699

Liver and intestine transplantation in the United States, 1997-2006.

R B Freeman1, D E Steffick, M K Guidinger, D G Farmer, C L Berg, R M Merion.   

Abstract

Liver transplantation in 2006 generally resembled previous years, with fewer candidates waiting for deceased donor liver transplants (DDLT), continuing a trend initiated with the implementation of the model for end-stage liver disease (MELD). Candidate age distribution continued to skew toward older ages with fewer children listed in 2006 than in any prior year. Total transplants increased due to more DDLT with slightly fewer living donor liver transplants (LDLT). Waiting list deaths and time to transplant continued to improve. In 2006, there also were fewer DDLT for patients with MELD <15, fewer pediatric Status 1A/B transplants and more transplants from donation after cardiac death (DCD) donors. Adjusted patient and graft survival rates were similar for LDLT and DDLT. This article also contains in-depth analyses of transplantation for hepatocellular carcinoma (HCC). Recipients with HCC had lower adjusted 3-year posttransplant survival than recipients without HCC. HCC recipients who received pretransplant ablative treatments had superior adjusted 3-year posttransplant survival compared to HCC recipients who did not. Intestinal transplantation continued to slowly increase with the largest number of candidates on the waiting list since 1997. Survival rates have increased over time. Small children waiting for intestine grafts continue to have the highest waiting list mortality.

Entities:  

Mesh:

Year:  2008        PMID: 18336699     DOI: 10.1111/j.1600-6143.2008.02174.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  68 in total

Review 1.  Integration of palliative care in end-stage liver disease and liver transplantation.

Authors:  Jamie Potosek; Michael Curry; Mary Buss; Eva Chittenden
Journal:  J Palliat Med       Date:  2014-11       Impact factor: 2.947

2.  Outcomes of treatment for hepatitis C virus infection by primary care providers.

Authors:  Sanjeev Arora; Karla Thornton; Glen Murata; Paulina Deming; Summers Kalishman; Denise Dion; Brooke Parish; Thomas Burke; Wesley Pak; Jeffrey Dunkelberg; Martin Kistin; John Brown; Steven Jenkusky; Miriam Komaromy; Clifford Qualls
Journal:  N Engl J Med       Date:  2011-06-01       Impact factor: 91.245

Review 3.  Biliary complications in living liver donors.

Authors:  Yufeng Yuan; Mitsukazu Gotoh
Journal:  Surg Today       Date:  2010-04-28       Impact factor: 2.549

4.  Ethnic advantages in kidney transplant outcomes: the Hispanic Paradox at work?

Authors:  Elisa J Gordon; Juan Carlos Caicedo
Journal:  Nephrol Dial Transplant       Date:  2008-12-15       Impact factor: 5.992

Review 5.  Living donor liver transplantation: eliminating the wait for death in end-stage liver disease?

Authors:  Robert A Fisher
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-02-15       Impact factor: 46.802

6.  Awareness of biologically confirmed HCV among a community residing sample of drug users in Baltimore City.

Authors:  Nicole Ennis Whitehead; Lauren E Hearn; Michael Marsiske; Maria R Kahn; William W Latimer
Journal:  J Community Health       Date:  2014-06

Review 7.  Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.

Authors:  Maurizio Pompili; Giampiero Francica; Francesca Romana Ponziani; Roberto Iezzi; Alfonso Wolfango Avolio
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

8.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

9.  Primary Care Physician Perspectives on Hepatitis C Management in the Era of Direct-Acting Antiviral Therapy.

Authors:  Mary Thomson; Monica A Konerman; Hetal Choxi; Anna S F Lok
Journal:  Dig Dis Sci       Date:  2016-03-08       Impact factor: 3.199

Review 10.  Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.

Authors:  René Fahrner; Felix Dondorf; Michael Ardelt; Yves Dittmar; Utz Settmacher; Falk Rauchfuß
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.